![]() |
市場調查報告書
商品編碼
1949570
大腸直腸外科手術市場 - 全球產業規模、佔有率、趨勢、機會及預測(按類型、產品、最終用戶、地區和競爭格局分類),2021-2031年Colorectal Surgery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Product, By End-User, By Region & Competition, 2021-2031F |
||||||
全球大腸直腸手術市場預計將從 2025 年的 194.5 億美元成長到 2031 年的 308.4 億美元,複合年成長率為 7.99%。
此細分市場涵蓋用於診斷和治療大腸直腸和肛門良惡性疾病(例如結腸癌和發炎性腸道疾病)的專用醫療設備和外科手術。市場擴張的主要原因是全球人口老化以及需要切除手術和結腸造口術的胃腸道疾病盛行率不斷上升。根據美國癌症協會 (ACS) 估計,到 2025 年,美國新增大腸癌病例預計將達到 154,270 例。日益加重的疾病負擔持續推高了對外科器械的需求,直接推動了市場成長。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 194.5億美元 |
| 市場規模:2031年 | 308.4億美元 |
| 複合年成長率:2026-2031年 | 7.99% |
| 成長最快的細分市場 | 低位前切除術 |
| 最大的市場 | 北美洲 |
然而,由於先進機器人系統和尖端電外科設備需要大量資本投資,市場面臨許多障礙。這些高昂的實施和維修成本往往阻礙了微創手術技術在醫療基礎設施低度開發地區的廣泛應用,也阻礙了其在價格敏感地區的市場滲透。因此,醫療機構面臨的巨大財務挑戰可能會延緩手術室的現代化改造,並阻礙高品質大腸直腸疾病診療方案在全球範圍內的普及。
全球大腸直腸癌和發炎性腸道疾病發生率的上升是推動大腸直腸外科手術市場發展的主要因素,刺激了對切除手術和治療程序的需求成長。消化器官系統惡性腫瘤病情的日益嚴重迫使醫療機構加強外科手術能力,以滿足越來越多需要複雜治療的患者的需求。世界衛生組織(世衛組織)於2024年2月發布的題為《全球癌症負擔》的新聞稿指出,大腸直腸癌是全球第二大癌症相關死亡原因,每年約造成90萬人死亡。如此高的死亡率和發病率直接導致醫院採購手術縫合器、能量器械和電外科設備的需求增加,以期透過及時的手術干預改善患者的治療效果。
同時,機器人手術和微創手術技術的快速普及正在改變外科手術環境,帶來更高的精準度和更短的恢復時間。這種轉變推動了對先進機器人平台和相容器械的需求,尤其是在強調以價值為導向的先進醫療體系中。根據直覺外科公司(Intuitive Surgical)於2024年1月發布的“2023年第四季及全年財務業績”,全球達文西手術量同比成長約22%,證實了機器人輔助手術在普通外科領域的快速普及。此外,篩檢計畫的擴展也加劇了這項手術需求。英國國家醫療服務體系(NHS England)報告稱,2024年緊急癌症轉診病例達到創紀錄的300萬例,這將對結直腸外科資源產生顯著的後續需求。
先進外科系統所需的高額資本投入是限制大腸直腸外科市場成長的主要阻礙因素。醫療機構,尤其是在開發中國家和公立醫療機構,往往缺乏足夠的資金用於購買設備。機器人手術平台和現代電外科設備的高昂前期成本對許多醫療機構構成障礙,阻礙了它們從傳統開放性手術轉向微創技術。這種經濟壁壘直接限制了設備的安裝規模,從而減少了維持市場永續收入所必需的專用器械的重複銷售量。
營運負擔超過了初始實施成本,這進一步阻礙了醫院管理者對其外科設施進行現代化改造。據英國外科醫師學會稱,到2024年,機器人手術系統的資本支出至少為150萬美元,此外每年還需要10萬美元的持續維護成本。這些高昂的成本阻礙了市場滲透,製造商難以在對成本高度敏感的地區銷售其高階技術。因此,市場成長緩慢,普及率仍集中在高所得地區。這使得全球相當一部分大腸直腸疾病治療需求仍依賴傳統的低成本調查方法。
某些結直腸手術轉移到門診手術中心(ASC)進行,代表著一種由節省成本和以患者為中心的醫療模式驅動的結構性變革。微創手術技術的進步使得諸如複雜切除術等手術能夠在門診環境中安全進行,而保險報銷政策也傾向於選擇成本較低的醫療機構。這種轉變減輕了住院床位的壓力,同時確保符合條件的病患的臨床安全。正如Cardinal Health在2024年4月發表的題為《門診手術中心的快速成長》的報導中所指出的,預計未來十年在門診手術中心進行的手術數量將至少成長25%,該文章強調了這種去中心化的趨勢。
人工智慧 (AI) 在外科手術決策支援中的應用,正將外科手術從機械輔助轉變為數據驅動的智慧手術。製造商正將機器學習技術整合到內視鏡系統中,以提供即時輔助,例如自動息肉檢測,從而標準化治療結果並減少操作者差異。這種整合透過提高篩檢和切除過程中的診斷準確性來滿足臨床需求。根據 2024 年 11 月題為“Medtronic美國退伍軍人事務部契約,以擴展 GI Genius AI 技術”的新聞稿,美國退伍軍人事務部已簽署契約,採購約 100 台額外的 AI 內視鏡設備,這標誌著智慧診斷設備在醫療機構中的應用正在加速普及。
The Global Colorectal Surgery Market is anticipated to expand from USD 19.45 Billion in 2025 to USD 30.84 Billion by 2031, reflecting a 7.99% CAGR. This sector encompasses specialized medical devices and surgical interventions designed to diagnose and treat benign and malignant ailments of the colon, rectum, and anus, such as colorectal cancer and inflammatory bowel disease. Market expansion is chiefly fueled by an increasingly aging global demographic and a growing prevalence of gastrointestinal disorders requiring resection or ostomy surgeries. According to the American Cancer Society, estimates suggested 154,270 new colorectal cancer diagnoses in the United States in 2025. This rising disease burden generates consistent demand for surgical tools, directly underpinning the market's growth trajectory.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 19.45 Billion |
| Market Size 2031 | USD 30.84 Billion |
| CAGR 2026-2031 | 7.99% |
| Fastest Growing Segment | Low Anterior Resection |
| Largest Market | North America |
However, the market encounters substantial obstacles due to the steep capital expenditure necessitated by advanced robotic systems and modern electrosurgical equipment. These high acquisition and upkeep costs frequently hinder the uptake of minimally invasive methods in developing healthcare infrastructures and constrain market penetration in price-sensitive geographies. As a result, significant financial hurdles within medical institutions can postpone the modernization of surgical suites and obstruct the wider dissemination of premium colorectal care solutions on a global scale.
Market Driver
The rising global incidence of colorectal cancer and inflammatory bowel disease acts as the primary catalyst for the colorectal surgery market, driving a greater need for resections and therapeutic measures. As the severity of gastrointestinal malignancies grows, healthcare providers are forced to bolster their surgical capacities to handle the volume of patients needing complex treatments. According to a World Health Organization press release in February 2024 titled 'Global Cancer Burden,' colorectal cancer stood as the second leading cause of cancer-related mortality globally, responsible for roughly 900,000 deaths. This high mortality and incidence rate leads directly to increased acquisition of surgical staplers, energy devices, and electrosurgical units as hospitals aim to enhance patient results through prompt surgical intervention.
Concurrently, the swift uptake of robotic and minimally invasive surgical methods is reshaping the procedural environment by delivering superior precision and faster recovery periods. This transition propels the demand for sophisticated robotic platforms and compatible tools, especially within developed healthcare systems that emphasize value-based care. According to Intuitive Surgical's 'Fourth Quarter and Full Year 2023 Financial Results' released in January 2024, worldwide da Vinci procedures increased by approximately 22% year-over-year, underscoring the quickening adoption of robotic aid in general surgery. Moreover, expanded screening programs are heightening this surgical need; NHS England reported delivering a record 3 million urgent cancer referrals in 2024, generating a significant downstream necessity for colorectal surgical resources.
Market Challenge
The substantial capital investment needed for advanced surgical systems acts as a major constraint on the colorectal surgery market's growth. Medical institutions, notably in developing countries and publicly funded networks, frequently function with limited budgets for capital equipment. The high initial costs for robotic platforms and contemporary electrosurgical units are prohibitive for numerous facilities, hindering the shift from conventional open surgery to minimally invasive techniques. This financial obstacle directly restricts the installed equipment base, which consequently diminishes the recurring sales volume of proprietary instruments required for sustained market revenue.
The operational strain extends past the initial acquisition, further discouraging hospital administrators from modernizing their surgical facilities. According to the Royal College of Surgeons of England, in 2024, the capital expense for a robotic surgical system was at least $1.5 million, accompanied by recurring annual maintenance fees of $100,000. These steep costs generate a gap in market penetration, as manufacturers face challenges selling premium technologies in cost-conscious regions. Consequently, the market sees decelerated growth rates as adoption remains focused in high-income areas, leaving a significant segment of global colorectal care demand dependent on older, less costly methodologies.
Market Trends
The shift of specific colorectal procedures to Ambulatory Surgery Centers (ASCs) signifies a structural evolution motivated by cost reduction and patient-centered care models. Improvements in minimally invasive methods now permit the safe execution of interventions such as complex polypectomies in outpatient environments, encouraged by reimbursement policies that favor lower-cost locations. This move relieves pressure on inpatient capacity while upholding clinical safety standards for suitable patients. As stated in the 'Rapid growth for ambulatory surgery centers' article by Cardinal Health in April 2024, the volume of surgical procedures conducted in ASCs is expected to increase by at least 25% over the coming decade, emphasizing the momentum of this decentralization trend.
The implementation of Artificial Intelligence for surgical decision support is transforming the sector, shifting it from mechanical aid to data-driven intelligent surgery. Manufacturers are embedding machine learning into endoscopic systems to offer real-time assistance, such as automated polyp detection, which normalizes outcomes and lessens operator variability. This incorporation meets clinical demands by improving diagnostic precision during screening and resection. According to the 'Medtronic awarded VA contract to expand GI Genius AI technology' press release from November 2024, the U.S. Department of Veterans Affairs concluded an agreement to install nearly 100 additional AI-enabled endoscopy units, highlighting the quickening institutional uptake of intelligent diagnostic instruments.
Report Scope
In this report, the Global Colorectal Surgery Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Colorectal Surgery Market.
Global Colorectal Surgery Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: